Search | IOVS | ARVO Journals

Showing 1 – 20 of 34

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Chalazion Frequency During the COVID-19 Pandemic

Matthew Lin; Kyle J Godfrey; Kira L Segal; Gary J Lelli

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):OD21.

ARVO Annual Meeting Abstract June 2023

Orbital Volume and Globe Position Changes Following Orbital Bone Removal Surgery

Quillan M Austria; Allison V Coombs; Victoria S. North; Maria D Garcia; Andrew YJ Lee; Kira L Segal; Gary J Lelli; Kyle J Godfrey

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4065.

ARVO Annual Meeting Abstract June 2023

Treatment Patterns, Outcomes, and Time-Investment in Symptomatic Epiphora due to Partial Nasolacrimal Duct Obstruction: Dacryocystorhinostomy vs. Nasolacrimal Duct Probing-Based Modalities

Alina Husain; Victoria S. North; Daniel K Lee; Aravindh Nirmalan; Ahmed B Sheik; Maria D Garcia; Kira L Segal; Gary J Lelli; Andrea A. Tooley; Ann Q Tran; Kyle J Godfrey

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4059.

ARVO Annual Meeting Abstract June 2023

Incidence of Blepharoptosis Following Intravitreal Anti-Vascular Endothelial Growth Factor Injections

Andrew YongJae Lee; Kyle Kovacs; Anton Orlin; Szilard Kiss; Donald D'Amico; Kira L Segal; Gary J Lelli; Kyle J Godfrey

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2210.

ARVO Annual Meeting Abstract June 2020

Prevalence of Preexisting Conditions in Thyroid Eye Disease Patients Who are Candidates for Teprotumumab Therapy from a Single Center in the United States

Jason Lin Chien; Gary J Lelli

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2937.

ARVO Annual Meeting Abstract July 2019

Improvement in Ophthalmology Operating Room Turnover Times with Implementation of Workflow Efficiency Measures

KYLE J GODFREY; Andrea A Tooley; Gary Lelli

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5507.

ARVO Annual Meeting Abstract July 2019

Utility of PROSE in thyroid eye disease patients with recurrent proptosis after orbital decompression

Kalla A Gervasio; Kyle J. Godfrey; James P Winebrake; Michelle N. Lee; Kimberly C Sippel; Edward C. Lai; Gary Lelli

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6217.

ARVO Annual Meeting Abstract July 2019

Lacrimal tissue resection and dry eye in Fasanella-Servat Operation

Shani Golan; Gary Lelli; Cynthia Magro

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6224.

ARVO Annual Meeting Abstract July 2019

Applying Lean methodology in assessment and intervention to improve process flow in an academic glaucoma practice.

James P Winebrake; Owen Drinkwater; Stephanie Muylaert; Gary Lelli

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5502.

ARVO Annual Meeting Abstract July 2019

Private Equity Acquisitions in Ophthalmology in the United States.

Eloise May ODonnell; Sami Bhidya; Gary Lelli; Lawrence Peter Casalino

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5486.

ARVO Annual Meeting Abstract July 2018

Visual acuity trends of patients wearing PROSE for exposure keratopathy after oculoplastic surgery

Kalla A Gervasio; Elizabeth Marlow; Michelle N. Lee; Gary J. Lelli

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):99.

ARVO Annual Meeting Abstract June 2017

Balloon dilation in endoscopic dacryocystorhinostomy vs. traditional endoscopic dacryocystorhinostomy for acquired nasolacrimal duct obstruction

Abdallah Mahrous; Paul Petrakos; Ashutosh Kacker; Gary Joseph Lelli

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3842.

ARVO Annual Meeting Abstract September 2016

Targeted Endoscopic Dacryocystorhinostomy for Acquired Nasolacrimal Duct Obstruction

Paul Petrakos; Ashutosh Kacker; Joshua Ian Levinger; Gary Lelli

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):687.

ARVO Annual Meeting Abstract September 2016

BI-INSTITUTIONAL RETROSPECTIVE REVIEW ON THE DEMOGRAPHICS AND BASIC CLINICAL PRESENTATION OF HIDROCYSTOMAS

Michelle Milee Chang; Paul Petrakos; Mei Zhou; Benjamin Levine; Gary Lelli; Pete Setabutr

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):697.

ARVO Annual Meeting Abstract September 2016

PROSE lens use for exposure keratopathy in trigeminal and facial nerve palsies

Elizabeth Marlow; Jessica Ciralsky; Michelle Lee; Gary Lelli

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3861.

ARVO Annual Meeting Abstract June 2015

Surgical treatment of proptosis secondary to Thyroid Eye Disease without a cutaneous incision

Paul Petrakos; Benjamin M Levine; Ashutosh Kacker; Aaron Pearlman; Gary J Lelli

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):570.

ARVO Annual Meeting Abstract June 2015

Congenital conjunctival choristomas

Kelley J Bohm; Gary J Lelli; Ana G Alzaga Fernandez; Jessica B Ciralsky

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3028.

ARVO Annual Meeting Abstract June 2015

A Retrospective Study Comparing Lateral Tarsal Strip with Everting Sutures to Two Other Surgical Methods for Lower Lid Involutional Entropion Repair

Ru-ik Chee; Gary J Lelli; Benjamin M Levine; Lorraine Cassidy

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4745.

ARVO Annual Meeting Abstract April 2014

Outcomes in cataract surgery at a major tertiary center: an effort towards improvement in quality reporting

Anthony Choi; Gary J Lelli

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2536.

ARVO Annual Meeting Abstract April 2014

Ptosis from levator dehiscence, fatty infiltration, and surgical outcomes

Margaret McGlynn; Benjamin M Levine; Charles Kim; Gary J Lelli

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3105.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Specify Date Range

Chalazion Frequency During the COVID-19 Pandemic

Orbital Volume and Globe Position Changes Following Orbital Bone Removal Surgery

Treatment Patterns, Outcomes, and Time-Investment in Symptomatic Epiphora due to Partial Nasolacrimal Duct Obstruction: Dacryocystorhinostomy vs. Nasolacrimal Duct Probing-Based Modalities

Incidence of Blepharoptosis Following Intravitreal Anti-Vascular Endothelial Growth Factor Injections

Prevalence of Preexisting Conditions in Thyroid Eye Disease Patients Who are Candidates for Teprotumumab Therapy from a Single Center in the United States

Improvement in Ophthalmology Operating Room Turnover Times with Implementation of Workflow Efficiency Measures

Utility of PROSE in thyroid eye disease patients with recurrent proptosis after orbital decompression

Lacrimal tissue resection and dry eye in Fasanella-Servat Operation

Applying Lean methodology in assessment and intervention to improve process flow in an academic glaucoma practice.

Private Equity Acquisitions in Ophthalmology in the United States.

Visual acuity trends of patients wearing PROSE for exposure keratopathy after oculoplastic surgery

Balloon dilation in endoscopic dacryocystorhinostomy vs. traditional endoscopic dacryocystorhinostomy for acquired nasolacrimal duct obstruction

Targeted Endoscopic Dacryocystorhinostomy for Acquired Nasolacrimal Duct Obstruction

BI-INSTITUTIONAL RETROSPECTIVE REVIEW ON THE DEMOGRAPHICS AND BASIC CLINICAL PRESENTATION OF HIDROCYSTOMAS

PROSE lens use for exposure keratopathy in trigeminal and facial nerve palsies

Surgical treatment of proptosis secondary to Thyroid Eye Disease without a cutaneous incision

Congenital conjunctival choristomas

A Retrospective Study Comparing Lateral Tarsal Strip with Everting Sutures to Two Other Surgical Methods for Lower Lid Involutional Entropion Repair

Outcomes in cataract surgery at a major tertiary center: an effort towards improvement in quality reporting

Ptosis from levator dehiscence, fatty infiltration, and surgical outcomes

To View More...

You must be signed into an individual account to use this feature.